• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: APOLLO ENDOSURGERY ORBERA365 INTRAGASTRIC BALLOON SYSTEM; IMPLANT, INTRAGASTRIC FOR MORBID OBESITY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

APOLLO ENDOSURGERY ORBERA365 INTRAGASTRIC BALLOON SYSTEM; IMPLANT, INTRAGASTRIC FOR MORBID OBESITY Back to Search Results
Model Number B-50012
Device Problems Fluid/Blood Leak (1250); Material Separation (1562)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 02/01/2024
Event Type  malfunction  
Manufacturer Narrative
Block h6: impact code f1001 is being used to capture the reportable issue of aborted/cancelled procedure with a patient under anesthesia.
 
Event Description
It was reported to boston scientific corporation that an orbera365 intragastric balloon was going to be implanted on (b)(6) 2024.During preparation, outside the patient, the balloon had a dislocated cylindrical silicone end and at the first manipulation the balloon was leaking.The procedure was not completed.There were no patient complications reported as a result of this event.No further information has been obtained despite good faith efforts.
 
Manufacturer Narrative
Block e2: health professional was approximated to yes as the event was reported to have occurred at a health care facility.Block h6: impact code f1001 is being used to capture the reportable issue of aborted/cancelled procedure with a patient under anesthesia.Block h10: investigation summary: with all the available information boston scientific concludes that the as reported code of balloon sheath material separation can be confirmed; however, the reported code of fluid leak could not be verified as the device did not leak during functional testing.Device history review.A review of the manufacturing documentation for this device revealed that no anomalies or deviations related to the event occurred during manufacturing.Device product analysis.Balloon was received with the bottom portion of the sheath detached.The remaining sheath is attached on the top portion of the balloon at the valve.The fill tip is connected into the valve.There is remanence of sodium bicarbonate present on the shell.Under microscopic analysis, the sheath appears to have been ripped off.A leak test was performed and there were no leaks observed on the shell or from the valve.Labeling review.A labeling review was performed and, from the information available, this device was used per the instructions for use (ifu) / product label.Risk review.A risk review of the orbera was completed and confirmed that the event of sheath material separation and fluid leak were defined in the risk documentation.This event type has been accounted for during product risk analysis to support acceptable risk benefit for the product.Investigation conclusion.Based on the information provided, the balloon was received with the bottom portion of the sheath detached.The most probable cause selected for this investigation will be manufacturing deficiency since the problem is traced to manufacturing process.During functional testing, there was no leak observed; therefore, the as reported code of fluid leak could not be verified.
 
Event Description
It was reported to boston scientific corporation that an orbera365 intragastric balloon was going to be implanted on (b)(6) 2024.During preparation, outside the patient, the balloon had a dislocated cylindrical silicone end and at the first manipulation the balloon was leaking.The procedure was not completed.There were no patient complications reported as a result of this event.No further information has been obtained despite good faith efforts.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ORBERA365 INTRAGASTRIC BALLOON SYSTEM
Type of Device
IMPLANT, INTRAGASTRIC FOR MORBID OBESITY
Manufacturer (Section D)
APOLLO ENDOSURGERY
1120 s. capital of texas hwy
bldg 1 suite 300
austin TX 78746
Manufacturer (Section G)
APOLLO ENDOSURGERY COSTA RICA S.R.L
alajuela, 02
CS  
Manufacturer Contact
carole morley
300 boston scientific way
marlborough, MA 01752
5086834015
MDR Report Key18803643
MDR Text Key336512246
Report Number3005099803-2024-00804
Device Sequence Number1
Product Code LTI
Combination Product (y/n)N
Reporter Country CodeIT
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional,Distributor
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date 04/24/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberB-50012
Device Lot NumberAF05689
Was Device Available for Evaluation? Device Returned to Manufacturer
Initial Date Manufacturer Received Not provided
Initial Date FDA Received02/28/2024
Supplement Dates Manufacturer Received04/03/2024
Supplement Dates FDA Received04/24/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured09/01/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-